B3 – Hazardous Pharmaceutical Waste: EPA Update

Cumberland 1/2

Pharmaceuticals that are considered hazardous drugs under the United States Pharmacopoeia (USP) are not necessarily the same drugs that become hazardous pharmaceutical waste under the Environmental Protection Agency (EPA). When someone says “hazardous drugs” how does a healthcare provider know which rules and standards apply, when they apply, and what Personal Protection Equipment (PPE) must be used?

These are questions healthcare providers will have to address shortly after CleanMed 2019. New standards of the United States Pharmacopoeia (USP) are expected to be in place through USP General Chapter <800> Hazardous Drugs – Handling in Healthcare Settings. Healthcare providers will also continue to follow Environmental Protection Agency (EPA) rules and state rules for managing hazardous pharmaceutical waste, including new EPA subpart P. Regulations on the management and disposal of controlled substances in 2014 will also be included in this discussion.

This presentation will identify and simplify the complex regulatory and environmental issues governing the management and disposal of pharmaceutical, hazardous pharmaceutical wastes, and controlled substances, each of which are regulated and managed differently. The presentation will be interactive and include a Q&A session with clinical pharmaceutical, sustainability, and regulatory experts. The participant will walk away with a complete understanding and management strategy to identify and dispose of these wastes in a cost effective and environmentally responsible manner.